Evaluation of IGF-I levels and serum protein profiles of diabetic cats and dogs

Journal of Veterinary Science

Volumn 12, Issue 4, 2011, Pages 325-331

  Ciftci, Gulay ^a   Yarim, Gul Fatma ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Cat; diabetes mellitus; Dog; IGF I; Serum protein profile

Indexed keywords

INSULIN; PLASMA PROTEIN; SOMATOMEDIN C;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; DOG; DOG DISEASE; GLUCOSE BLOOD LEVEL; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANIMALS; BLOOD GLUCOSE; BLOOD PROTEINS; CAT DISEASES; CATS; DIABETES MELLITUS, TYPE 2; DOG DISEASES; DOGS; INSULIN; INSULIN-LIKE GROWTH FACTOR I;

ANIMALIA; CANIS FAMILIARIS;

EID: 84860785359     PISSN: 1229845X     EISSN: None     Source Type: Journal    
DOI: 10.4142/jvs.2011.12.4.325     Document Type: Article

References (47)

1. Asada T, Takakura S, Ogawa T, Iwai M, Kobayashi M. Overexpression of glucose transporter rotein 5 in sciatic nerve of streptozotocin-induced diabetic rats. Neurosci Lett 1998, 252, 111-114.
2. Aytuĝ N. Metabolizma hastaliklari. In: İmren HY (ed.). Kedi ve Köpek Hastaliklari. pp. 345-346, Medisan Yayinlari, Ankara, 1998.
3. Bach LA, Rechler MM. Insulin-like growth factors and diabetes. Diabetes Metab Rev 1992, 8, 229-257.
4. Bach MA, Chin E, Bondy CA. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1994, 79, 1040-1045.
5. Banting FG, Best CH. Pancreatic extracts. 1922. J Lab Clin Med 1990, 115, 254-272.
6. Baxter RC. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 1988, 67, 265-272.
7. Bereket A, Lang CH, Wilson TA. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus. Horm Metab Res 1999, 31, 172-181.
8. Berg RIM, Nelson RW, Feldman EC, Kass PH, Pollard R, Refsal KR. Serum insulin-like growth factor-I concentration in cats with diabetes mellitus and acromegaly. J Vet Intern Med 2007, 21, 892-898.
9. Blum WF. Insulin-like growth factors and their binding proteins. In: Ranke MB (ed.). Diagnostics of Endocrine Function in Children and Adolescents. pp. 190-218, Barth Verlag, Heidelberg, 1996.
10. Boulware SD, Tamborlane WV, Rennert NJ, Gesundheit N, Sherwin RS. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults. J Clin Invest 1994, 93, 1131-1139.
11. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994, 79, 872-878.
12. Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B, Orecchia P, Zardi L, Righetti PG. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004, 25, 1327-1333.
13. Dai J, Baxter RC. Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex. Endocrinology 1994, 135, 2335-2341.
14. Dunger DB, Acerini CL. IGF-I and diabetes in adolescence. Diabetes Metab 1998, 24, 101-107.
15. Eigenmann JE, Becker M, Kammermann B, Leemann W, Heimann R, Zapf J, Froesch ER. Decrease of non-suppressible insulin-like activity after pancreatectomy and normalization by insulin therapy. Acta Endocrinol (Copenh) 1977, 85, 818-822.
16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26 (Suppl 1), S5-20.
17. Fryburg DA. Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism. Am J Physiol 1994, 267 (2 Pt 1), E331-336.
18. Frystyk J, Baxter RC. Competitive binding assay for determination of rat insulin-like growth factor binding protein-3. Endocrinology 1998, 139, 1454-1457.
19. Kratzsch J, Keliner K, Zilkens T, Schmidt-Gayk H, Selisko T, Scholz GH. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus. Clin Endocrinol (Oxf) 1996, 44, 673-678.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
21. Laronga C, Becker S, Watson P, Gregory B, Cazares L, Lynch H, Perry RR, Wright GL Jr, Drake RR, Semmes OJ. SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers. Dis Marker 2003-2004, 19, 229-238.
22. Lewitt MS, Hazel SJ, Church DB, Watson ADJ, Powell SE, Tan K. Regulation of insulin-like growth factor-binding protein-3 ternary complex in feline diabetes mellitus. J Endocrinol 2000, 166, 21-27.
23. Löfqvist C, Andersson E, Gelander L, Rosberg S, Hulthen L, Blum WF, Wikland KA. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. J Clin Endocrinol Metab 2005, 90, 1420-1427.
24. Massa R, Bantar C, Lopardo H, Vay C, Gutkind G. Whole-cell protein profiles are useful for distinguishing enterococcal species recovered from clinical specimens. Rev Argent Microbiol 2007, 39, 199-203.
25. Maxwell A, Butterwick R, Batt RM, Camacho-Hübner C. Serum insulin-like growth factor (IGF)-I concentrations are reduced by short-term dietary restriction and restored by refeeding in domestic cats (Felis catus). J Nutr 1999, 129, 1879-1884.
26. McMillan DE. Increased levels of acute-phase serum proteins in diabetes. Metabolism 1989, 38, 1042-1046.
27. Myers MG Jr, Sun XJ, Cheatham B, Jachna BR, Glasheen EM, Backer JM, White MF. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase. Endocrinology 1993, 132, 1421-1430.
28. O'Connell TX, Horita TJ, Kasravi B. Understanding and interpreting serum protein electrophoresis. Am Fam Physician 2005, 71, 105-112.
29. Okumus Z. Diabetes mellitus in dogs and cats Part 1: Etyology, pathogenesis and treatment. Kafkas Univ Vet Fak Derg 1999, 5, 223-231.
30. Rand JS, Fleeman LM, Farrow HA, Appleton DJ, Lederer R. Canine and feline diabetes mellitus: nature or nurture? J Nutr 2004, 134 (8 Suppl), 2072S-2080S.
31. Rand JS, Marshall RD. Diabetes Mellitus in Cats. Vet Clin North Am Small Anim Pract 2005, 35, 211-224.
32. Raynaud-Simon A, Perin L, Meaume S, Lesourd B, Moulias R, Postel-Vinay MC, Le Bouc Y. IGF-I, IGF-I-binding proteins and GH-binding protein in malnourished elderly patients with inflammation receiving refeeding therapy. Eur J Endocrinol 2002, 146, 657-665.
33. Reusch CE, Kley S, Casella M, Nelson RW, Mol J, Zapf J. Measurements of growth hormone and insulin-like growth factor 1 in cats with diabetes mellitus. Vet Rec 2006, 158, 195-200.
34. Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 1978, 253, 2769-2776.
35. Rosenfeld RG, Lamson G, Pham H, Oh Y, Conover C, De Leon DD, Donovan SM, Ocrant I, Giudice L. Insulinlike growth factor-binding proteins. Recent Prog Horm Res 1990, 46, 99-159.
36. Russell-Jones DL, Umpleby AM, Hennessy TR, Bowes SB, Shojaee-Moradie F, Hopkins KD, Jackson NC, Kelly JM, Jones RH, Sönksen PH. Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans. Am J Physiol 1994, 267 (4 Pt 1), E591-598.
37. Russell-Jones DL, Bates AT, Umpleby AM, Hennessy TR, Bowes SB, Hopkins KD, Jackson N, Kelly J, Shojaee-Moradie F, Jones RH, Sonksen PH. A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers. Eur J Clin Invest 1995, 25, 403-411.
38. Scheiwiller E, Guler HP, Merryweather J, Scandella C, Maerki W, Zapf J, Froesch ER. Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature 1986, 323, 169-171.
39. Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sönksen PH, Dunger DB, Umpleby AM. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes. J Clin Endocrinol Metab 2004, 89, 425-432.
40. Sjögren K, Wallenius K, Liu JL, Bohlooly-Y M, Pacini G, Svensson L, Törnell J, Isaksson OG, Ahrén B, Jansson JO, Ohlsson C. Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 2001, 50, 1539-1545.
41. Sönksen PH, Russell-Jones D, Jones RH. Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future? Horm Res 1993, 40, 68-79.
42. Starkey SR, Tan K, Church DB. Investigation of serum IGF-I levels amongst diabetic and non-diabetic cats. J Feline Med Surg 2004, 6, 149-155.
43. Struble AL, Nelson RW. Non insulin-dependent diabetes mellitus in cats and humans. Compend Contin Educ Pract Vet 1997, 19, 935-944.
44. Stogdale L. Definition of diabetes mellitus. Cornell Vet Med 1986, 76, 156-174.
45. Townsend JC. Increased albumin excretion in diabetes. J Clin Pathol 1990, 43, 3-8.
46. Wa C, Cerny RL, Clarke WA, Hage DS. Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chim Acta 2007, 385, 48-60.
47. Zerbé CA. What is so Special about Feline Diabetes Mellitus? J Feline Med Surg 2001, 3, 99-103.